Petros Pharmaceuticals, Inc. (PTPI) Operating income 2020–2025
Petros Pharmaceuticals, Inc. (PTPI) annual operating income history from SEC filings — each fiscal year as reported.
-$4.6MFY2025 · since FY2020: -$17.3M → -$4.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$4.6M | -0.3% |
| FY2024 | -$4.6M | +66.0% |
| FY2023 | -$13.6M | +31.6% |
| FY2022 | -$19.9M | -10.3% |
| FY2021 | -$18.0M | -4.4% |
| FY2020 | -$17.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice